Our results showed for the first time that melatonin enhanced the berberine-mediated growth inhibition of lung cancer cells through simultaneous modulation of caspase/cytochrome C, AP-2β/hTERT, NF-κB/COX-2, and Akt/ERK signaling pathways. The gene discussed is CYCS; the disease is lung cancer.